Symptoms associated with Lewy body disease in mild cognitive impairment

Paul C Donaghy1, Nicola Barnett1, Kirsty Olsen1

  • 1Institute for Ageing and Institute of Neuroscience, Newcastle University, UK.

Abstract

Insights

Early diagnosis of Lewy body disease in mild cognitive impairment (MCI) may be aided by specific symptoms. Fluctuations, confusion, and parkinsonian signs are key indicators for MCI-LB.

Area of Science:

  • Neurology
  • Cognitive Science
  • Geriatrics

Background:

  • Dementia with Lewy bodies (DLB) presents with diverse cognitive and non-cognitive symptoms.
  • Distinguishing DLB from Alzheimer's disease (AD) is crucial for appropriate management.
  • Mild cognitive impairment (MCI) can be an early stage of neurodegenerative diseases like DLB and AD.

Purpose of the Study:

  • To identify symptoms indicative of Lewy body disease in individuals with mild cognitive impairment (MCI).
  • To differentiate MCI due to Lewy bodies (MCI-LB) from MCI due to Alzheimer's disease (MCI-AD).
  • To develop a symptom-based scale for early detection of MCI-LB.

Main Methods:

  • Recruited participants with MCI-LB, MCI-AD, DLB, AD, and controls.
  • Utilized an interview-based questionnaire administered to participants and/or their carers.
  • Compared the prevalence of Lewy body-associated symptoms between diagnostic groups.

Main Results:

  • Symptoms like fluctuating attention, confusion, rigidity, handwriting changes, falls, drooling, and REM sleep behavior disorder (RBD) were more prevalent in MCI-LB and DLB.
  • Hyposmia, tremor, slowness, and autonomic symptoms were not specific to Lewy body disease.
  • A 10-point symptom scale achieved 83% sensitivity and 100% specificity in differentiating MCI-LB from MCI-AD.

Conclusions:

  • Drooling, misjudging objects, parkinsonism, fluctuating cognition, and RBD symptoms are characteristic of MCI-LB.
  • Slowness, tremor, autonomic dysfunction, and hyposmia are common but not specific to MCI-LB.
  • These findings support the use of specific symptom clusters for early MCI-LB diagnosis.

Related Concept Videos

Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
615
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
788
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.8K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K